Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.

Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso NE, Harris CC.

J Natl Cancer Inst. 2011 Jul 20;103(14):1112-22. doi: 10.1093/jnci/djr216. Epub 2011 Jun 17.

2.

Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.

Purdue MP, Lan Q, Bagni R, Hocking WG, Baris D, Reding DJ, Rothman N.

Cancer Res. 2011 Jul 15;71(14):4898-907. doi: 10.1158/0008-5472.CAN-11-0165. Epub 2011 Jun 1.

3.

Circulating inflammation markers and risk of epithelial ovarian cancer.

Clendenen TV, Lundin E, Zeleniuch-Jacquotte A, Koenig KL, Berrino F, Lukanova A, Lokshin AE, Idahl A, Ohlson N, Hallmans G, Krogh V, Sieri S, Muti P, Marrangoni A, Nolen BM, Liu M, Shore RE, Arslan AA.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):799-810. doi: 10.1158/1055-9965.EPI-10-1180. Epub 2011 Apr 5.

4.

Temporal reliability of cytokines and growth factors in EDTA plasma.

Clendenen TV, Arslan AA, Lokshin AE, Idahl A, Hallmans G, Koenig KL, Marrangoni AM, Nolen BM, Ohlson N, Zeleniuch-Jacquotte A, Lundin E.

BMC Res Notes. 2010 Nov 13;3:302. doi: 10.1186/1756-0500-3-302.

5.

Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population?

Vilarrasa N, Vendrell J, Maravall J, Elío I, Solano E, San José P, García I, Virgili N, Soler J, Gómez JM.

Endocrine. 2010 Oct;38(2):235-42. doi: 10.1007/s12020-010-9379-4. Epub 2010 Jul 23.

PMID:
21046484
6.

Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition.

Aleksandrova K, Jenab M, Boeing H, Jansen E, Bueno-de-Mesquita HB, Rinaldi S, Riboli E, Overvad K, Dahm CC, Olsen A, Tjønneland A, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Palli D, Krogh V, Tumino R, Vineis P, Panico S, Kaaks R, Rohrmann S, Trichopoulou A, Lagiou P, Trichopoulos D, van Duijnhoven FJ, Leufkens AM, Peeters PH, Rodríguez L, Bonet C, Sánchez MJ, Dorronsoro M, Navarro C, Barricarte A, Palmqvist R, Hallmans G, Khaw KT, Wareham N, Allen NE, Spencer E, Romaguera D, Norat T, Pischon T.

Am J Epidemiol. 2010 Aug 15;172(4):407-18. doi: 10.1093/aje/kwq135. Epub 2010 Jul 15.

7.

Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Zheng W, Danforth KN, Tworoger SS, Goodman MT, Arslan AA, Patel AV, McCullough ML, Weinstein SJ, Kolonel LN, Purdue MP, Shu XO, Snyder K, Steplowski E, Visvanathan K, Yu K, Zeleniuch-Jacquotte A, Gao YT, Hankinson SE, Harvey C, Hayes RB, Henderson BE, Horst RL, Helzlsouer KJ.

Am J Epidemiol. 2010 Jul 1;172(1):70-80. doi: 10.1093/aje/kwq118. Epub 2010 Jun 18.

8.

Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Purdue MP, Freedman DM, Gapstur SM, Helzlsouer KJ, Laden F, Lim U, Maskarinec G, Rothman N, Shu XO, Stevens VL, Zeleniuch-Jacquotte A, Albanes D, Bertrand K, Weinstein SJ, Yu K, Irish L, Horst RL, Hoffman-Bolton J, Giovannucci EL, Kolonel LN, Snyder K, Willett W, Arslan AA, Hayes RB, Zheng W, Xiang YB, Hartge P.

Am J Epidemiol. 2010 Jul 1;172(1):58-69. doi: 10.1093/aje/kwq117. Epub 2010 Jun 18.

9.

Vitamin D and the immune system: new perspectives on an old theme.

Hewison M.

Endocrinol Metab Clin North Am. 2010 Jun;39(2):365-79, table of contents. doi: 10.1016/j.ecl.2010.02.010. Review.

10.

Plasma cytokines and future risk of non-Hodgkin lymphoma (NHL): a case-control study nested in the Italian European Prospective Investigation into Cancer and Nutrition.

Saberi Hosnijeh F, Krop EJ, Scoccianti C, Krogh V, Palli D, Panico S, Tumino R, Sacredote C, Nawroly N, Portengen L, Linseisen J, Vineis P, Vermeulen R.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1577-84. doi: 10.1158/1055-9965.EPI-09-1237. Epub 2010 May 25.

11.

C-reactive protein and risk of lung cancer.

Chaturvedi AK, Caporaso NE, Katki HA, Wong HL, Chatterjee N, Pine SR, Chanock SJ, Goedert JJ, Engels EA.

J Clin Oncol. 2010 Jun 1;28(16):2719-26. doi: 10.1200/JCO.2009.27.0454. Epub 2010 Apr 26.

12.

Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.

Gu Y, Shore RE, Arslan AA, Koenig KL, Liu M, Ibrahim S, Lokshin AE, Zeleniuch-Jacquotte A.

Cancer Causes Control. 2010 Aug;21(8):1323-33. doi: 10.1007/s10552-010-9560-3. Epub 2010 Apr 7.

13.

Gene expression patterns in the human breast after pregnancy.

Asztalos S, Gann PH, Hayes MK, Nonn L, Beam CA, Dai Y, Wiley EL, Tonetti DA.

Cancer Prev Res (Phila). 2010 Mar;3(3):301-11. doi: 10.1158/1940-6207.CAPR-09-0069. Epub 2010 Feb 23.

14.

No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects.

Jorde R, Sneve M, Torjesen PA, Figenschau Y, Gøransson LG, Omdal R.

Cytokine. 2010 May;50(2):175-80. doi: 10.1016/j.cyto.2009.12.006. Epub 2010 Feb 1.

PMID:
20122848
15.

Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas.

Ho GY, Xue X, Cushman M, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Barry EL, Saibil F, Bresalier RS, Rohan TE, Baron JA.

J Natl Cancer Inst. 2009 Dec 2;101(23):1650-4. doi: 10.1093/jnci/djp346. Epub 2009 Oct 12.

16.

Circulating vitamin d and risk of epithelial ovarian cancer.

Arslan AA, Clendenen TV, Koenig KL, Hultdin J, Enquist K, Agren A, Lukanova A, Sjodin H, Zeleniuch-Jacquotte A, Shore RE, Hallmans G, Toniolo P, Lundin E.

J Oncol. 2009;2009:672492. doi: 10.1155/2009/672492. Epub 2009 Aug 27.

17.

Decreased high-density lipoprotein cholesterol level is an independent correlate of circulating tumor necrosis factor-alpha in a general population.

Yamagishi S, Adachi H, Matsui T, Nakamura K, Enomoto M, Fukami A, Otsuka M, Kumagae S, Nanjo Y, Imaizumi T.

Clin Cardiol. 2009 Sep;32(9):E29-32. doi: 10.1002/clc.20517.

18.

Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers.

Zittermann A, Frisch S, Berthold HK, Götting C, Kuhn J, Kleesiek K, Stehle P, Koertke H, Koerfer R.

Am J Clin Nutr. 2009 May;89(5):1321-7. doi: 10.3945/ajcn.2008.27004. Epub 2009 Mar 25.

19.

Serum 25-hydroxyvitamin d levels are not associated with subclinical vascular disease or C-reactive protein in the old order amish.

Michos ED, Streeten EA, Ryan KA, Rampersaud E, Peyser PA, Bielak LF, Shuldiner AR, Mitchell BD, Post W.

Calcif Tissue Int. 2009 Mar;84(3):195-202. doi: 10.1007/s00223-008-9209-3. Epub 2009 Jan 16.

20.

Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons.

Wong HL, Pfeiffer RM, Fears TR, Vermeulen R, Ji S, Rabkin CS.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3450-6. doi: 10.1158/1055-9965.EPI-08-0311.

Items per page

Supplemental Content

Write to the Help Desk